Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Lindor

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.
Gastroenterology|January 29, 2008
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapyAmaar Ghazale, Suresh T Chari, Lizhi Zhang, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Hepatology International|May 4, 2021
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitisGuiqiang Wang, Atsushi Tanaka, Hong Zhao, et al.
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2017
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health SystemsMei Lu, Jia Li, Irina V Haller, et al.
Clinical Epidemiology|November 18, 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary CholangitisMei Lu, Christopher L Bowlus, Keith Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With TreatmentMei Lu, Yueren Zhou, Irina V Haller, et al.
The American Journal of Gastroenterology|January 28, 2020
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary CholangitisStuart C Gordon, Kuan-Han Hank Wu, Keith Lindor, et al.
Digestive Diseases and Sciences|September 9, 2021
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USAJia Li, Mei Lu, Yueren Zhou, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.
Gastroenterology|January 29, 2008
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapyAmaar Ghazale, Suresh T Chari, Lizhi Zhang, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo, Jason M Hui, Giulio Marchesini, et al.
Hepatology International|May 4, 2021
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitisGuiqiang Wang, Atsushi Tanaka, Hong Zhao, et al.
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2017
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health SystemsMei Lu, Jia Li, Irina V Haller, et al.
Clinical Epidemiology|November 18, 2020
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary CholangitisMei Lu, Christopher L Bowlus, Keith Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 27, 2017
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With TreatmentMei Lu, Yueren Zhou, Irina V Haller, et al.
The American Journal of Gastroenterology|January 28, 2020
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary CholangitisStuart C Gordon, Kuan-Han Hank Wu, Keith Lindor, et al.
Digestive Diseases and Sciences|September 9, 2021
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USAJia Li, Mei Lu, Yueren Zhou, et al.
Pageof 7